[Expression of insulin receptor substrate 1 and phosphorylation of tyrosine in adipose tissue of polycystic ovary syndrome]
- PMID: 15840294
[Expression of insulin receptor substrate 1 and phosphorylation of tyrosine in adipose tissue of polycystic ovary syndrome]
Abstract
Objective: To study expression of insulin receptor substrate 1 (IRS-1) and phosphorylation of tyrosine in adipose tissue of polycystic ovary syndrome (PCOS) to approach the mechanism of insulin resistance (IR) in PCOS at tissue and cellular level.
Methods: IRS-1 expression and tyrosine phosphorylation of adipose tissue were studied with immunoprecipitation, Western-blot and ECL immunoblotting.
Results: The differences of IRS-1 expression in adipose tissue among the obese PCOS group (82 +/- 15)%, the non-obese PCOS group (79 +/- 18)%, the obese control group (75 +/- 19)% and the non obese control group (70 +/- 19)% were not significant (P > 0.05). IRS-1 tyrosine phosphorylation in adipose tissue in the obese PCOS group [(52 +/- 23)%, P < 0.001], the obese control group [(45 +/- 22)%, P < 0.01] and non-obese PCOS group [(70 +/- 25)%, P < 0.05] were markedly lower than that in the non-obese control group (88 +/- 12)%. The obese control group had more reduction than non-obese control group (P < 0.05). The differences between the obese PCOS group and the obese control group or the two PCOS groups were not significant (P > 0.05).
Conclusion: IRS-1 tyrosine phosphorylation in adipose tissue in the two PCOS groups decreased markedly than in the non-obese control group. It might be involved in the disorder of insulin-signaling transduction downstream of insulin receptor and the occurrence of IR.
Similar articles
-
[Tyrosine phosphorylation and protein expression of insulin receptor substrate-2 in the adipose tissue from patients with polycystic ovary syndrome].Zhonghua Fu Chan Ke Za Zhi. 2005 Feb;40(2):116-9. Zhonghua Fu Chan Ke Za Zhi. 2005. PMID: 15840293 Chinese.
-
[Tyrosine phosphorylation and protein expression of insulin receptor substrate-1 in the patients with polycystic ovary syndrome].Zhonghua Fu Chan Ke Za Zhi. 2004 Mar;39(3):176-9. Zhonghua Fu Chan Ke Za Zhi. 2004. PMID: 15130378 Chinese.
-
Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery.Hum Reprod. 2007 Apr;22(4):1003-10. doi: 10.1093/humrep/del466. Epub 2007 Jan 4. Hum Reprod. 2007. PMID: 17204522
-
Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?Panminerva Med. 2008 Dec;50(4):279-94. Panminerva Med. 2008. PMID: 19078869 Review.
-
Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity.J Pediatr Endocrinol Metab. 2000;13 Suppl 5:1291-3. J Pediatr Endocrinol Metab. 2000. PMID: 11117672 Review.
Cited by
-
Developmental programming of insulin resistance: are androgens the culprits?J Endocrinol. 2020 Jun;245(3):R23-R48. doi: 10.1530/JOE-20-0044. J Endocrinol. 2020. PMID: 32240982 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical